DFDA

Furosemide

Treatment for Alcoholic Cardiomyopathy

Typical Dosage: 20-80mg daily

Effectiveness
60%
Safety Score
65%
Clinical Trials
100
Participants
20K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
20-80mg daily
Time to Effect
immediate (hours)
Treatment Duration
as needed/lifetime
Evidence Quality
HIGH
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$300
Side Effect Mgmt:$100
Total Annual:$450
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$30,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$529
Comparison vs Placebo
Cost Difference
+$450/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
No dominance
Furosemide Outcomes

for Alcoholic Cardiomyopathy

Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+85%
Common Side Effects
Electrolyte imbalance (hypokalemia, hyponatremia)
+25%
Dizziness
+10%
Hypotension
+10%
Renal dysfunction
+5%

Sources:

nih.gov
nih.gov
escardio.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov